The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017

Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017

January 19, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

With the ACR/ARHP’s support, research funding for the National Institutes of Health was boosted by $2 billion in 2017 despite threats by the current administration to cut it. The ACR/ARHP raised awareness of the impact of arthritis on service members and veterans, including that it is the second leading cause of medical discharge from the Army behind battlefield injury, and is the leading cause of disability among veterans, resulting in continued support for arthritis research through the Department of Defense.

You Might Also Like
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • Year in Review: The Impact of Advocacy & RheumPAC in 2018
  • Update on Legislation, Advocacy Efforts to Advance Rheumatology
Explore This Issue
January 2018
Also By This Author
  • RheumPAC Advocates for Dept. of Defense Arthritis Research Funding

At the state level in 2017, the ACR/ARHP helped to pass biosimilar legislation in 10 states and step therapy laws in five states. MACRA education sessions were hosted by the ACR/ARHP during 22 rheumatology meetings throughout the country.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

2017 By the Numbers

  • Sent 22 letters to payers on policy coverage issues;
  • Reviewed or monitored 578 pieces of legislation;
  • Held over 265 meetings in Congressional offices;
  • Coordinated 40 active affiliate rheumatology societies;
  • ACR/ARHP members sent more than 3,775 emails to Congress on policy issues;
  • Facilitated publication of 88 media stories, op-eds and letters to the editor advancing ACR’s policy positions;
  • Supported more than 50 fundraisers for members of Congress and candidates through RheumPAC; and
  • Drew more than 1 million views and social media impressions of the #Act4Arthritis hashtag.

The ACR/ARHP is gearing up for our 2018 policy efforts, including continued work through the AMA and 14 current policy coalitions. We hope that you will help keep the momentum going by letting lawmakers know of your concerns through the ACR/ARHP Legislative Action Center or by investing in RheumPAC. Visit www.rheumatology.org/Advocacy to learn more.

Pages: 1 2 | Single Page

Filed Under: From the College, President's Perspective, Professional Topics Tagged With: AC&R, Advocacy, American College of Rheumatology, ARHP, Association of Rheumatology Health Professionals, Legislation, RheumPACIssue: January 2018

You Might Also Like:
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • Year in Review: The Impact of Advocacy & RheumPAC in 2018
  • Update on Legislation, Advocacy Efforts to Advance Rheumatology
  • New D.C. Office Strengthens ACR Advocacy Efforts

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.